A directory of where to buy chemicals in the USA, including: distributors, industrial manufacturers, bulk supplies and wholesalers of raw ingredients & finished goods.
Search for products or services, then visit the suppliers website for prices or more information.
| Product | Description | |
|---|---|---|
| Daclatasvir Impurity 6 | Daclatasvir Impurity 6. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2077207-88-4. Molecular Formula: C41H52N8O6. Mole Weight: 752.92. Catalog: APB2077207884. |  |
| Daclatasvir Impurity 6 | Daclatasvir SRRS Isomer is an isomer of Daclatasvir, a compound that inhibits the HCV protein NS5A, and thus can be used as a drug candidate for the treatment of hepatitis C (HCV). Synonyms: Daclatasvir SRRS Isomer; N,N'-[[1,1'-Biphenyl]-4,4'-diylbis[1H-imidazole-5,2-diyl-(2R)-2,1-pyrrolidinediyl[(1S)-1-(1-methylethyl)-2-oxo-2,1-ethanediyl]]]biscarbamic Acid C,C'-Dimethyl Ester. Grades: > 95%. CAS No. 1009117-26-3. Molecular formula: C40H50N8O6. Mole weight: 738.88. |  |
| Daclatasvir Impurity 7 | Daclatasvir Impurity 7. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C40H49N7O7. Mole Weight: 739.87. Catalog: APB12391. | |
| Daclatasvir Impurity 8 | Daclatasvir Impurity 8. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2226541-13-3. Molecular Formula: C35H41N7O4. Mole Weight: 623.76. Catalog: APB2226541133. | |
| Daclatasvir Impurity 9 | Daclatasvir Impurity 9. Uses: For analytical and research use. Group: Impurity standards. CAS No. 1007884-60-7. Molecular Formula: C33H39N7O3. Mole Weight: 581.72. Catalog: APB1007884607. | |
| Daclizumab | Daclizumab is a humanized monoclonal antibody of the human IgG1 isotype that binds specifically to the Tac epitope on the α-subunit (CD25) of the IL-2R. Synonyms: Zenapax; Ro 24-7375. CAS No. 152923-56-3. Molecular formula: C6332H9808N1678O1989S42. Mole weight: 142612.1. | |
| Daclizumab | Daclizumab (Zenapax) is a humanized, monoclonal antibody that blocks CD25 (α-subunit of the high-affinity interleukin-2 receptor (IL-2R-HA)). Daclizumab (Zenapax) reversibly binds to CD25and prevents the interaction of IL-2 with the IL-2R-HA. Daclizumab (Zenapax) can be used for multiple sclerosis research [1]. Uses: Scientific research. Group: Inhibitory antibodies. Alternative Names: Zenapax; Ro 24-7375. CAS No. 152923-56-3. Pack Sizes: 1 mg; 5 mg; 10 mg. Product ID: HY-108738. |  |
| DACM | DACM (N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide) is a thiol-directed fluorescent dye (Ex=396 nm, Em=468 nm) [1]. Uses: Scientific research. Group: Fluorescent dye. Alternative Names: N-(7-Dimethylamino-4-methyl-3-coumarinyl)maleimide. CAS No. 55145-14-7. Pack Sizes: 1 mg. Product ID: HY-121030. | |
| DACN(Ms) hydrochloride | SPAAC & SPANC Click Reaction. Group: Dbco. Alternative Names: DACN(Ms)*HCl. CAS No. 2331322-16-6. Molecular formula: C8H15ClN2O2S. Mole weight: 238.74. IUPACName: 1-Methylsulfonyl-1,5-diazacyclonon-7-yne;hydrochloride. Canonical SMILES: CS(=O)(=O)N1CCCNCC#CC1.Cl. Catalog: CCR2331322166. |  |
| DACN(Ms,Ns) | SPAAC & SPANC Click Reaction. Group: Dbco. CAS No. 2411082-25-0. Molecular formula: C14H17N3O6S2. Mole weight: 387.4. IUPACName: 1-Methylsulfonyl-5-(2-nitrophenyl)sulfonyl-1,5-diazacyclonon-7-yne. Canonical SMILES: CS (=O) (=O)N1CCCN (CC#CC1)S (=O) (=O)C2=CC=CC=C2[N+] (=O)[O-]. Catalog: CCR2411082250. | |
| DACN(Tos2) | SPAAC & SPANC Click Reaction. Group: Dbco. Alternative Names: N,N'-Bis(p-toluenesulfonyl)-4,8-diazacyclononyne 1,5-Ditosyl-2,3,4,5,6,9-hexahydro-7,8-didehydro-1H-1,5-diazonine. CAS No. 1797508-57-6. Molecular formula: C21H24N2O4S2. Mole weight: 432.6. IUPACName: 1,5-Bis-(4-methylphenyl)sulfonyl-1,5-diazacyclonon-7-yne. Canonical SMILES: CC1=CC=C (C=C1)S (=O) (=O)N2CCCN (CC#CC2)S (=O) (=O)C3=CC=C (C=C3)C. Catalog: CCR1797508576. | |
| DACN(Tos2,6-OH) | SPAAC & SPANC Click Reaction. Group: Dbco. CAS No. 2109751-74-6. Molecular formula: C21H24N2O5S2. Mole weight: 448.6. IUPACName: 1,5-Bis-(4-methylphenyl)sulfonyl-1,5-diazacyclonon-7-yn-3-ol. Canonical SMILES: CC1=CC=C (C=C1)S (=O) (=O)N2CC#CCN (CC (C2)O)S (=O) (=O)C3=CC=C (C=C3)C. Catalog: CCR2109751746. | |
| DACN(Tos) hydrochloride | SPAAC & SPANC Click Reaction. Group: Dbco. Alternative Names: DACN(Tos)*HCl. CAS No. 2331322-18-8. Molecular formula: C14H19ClN2O2S. Mole weight: 314.8. IUPACName: 1-(4-Methylphenyl)sulfonyl-1,5-diazacyclonon-7-yne;hydrochloride. Canonical SMILES: CC1=CC=C(C=C1)S(=O)(=O)N2CCCNCC#CC2. Cl. Catalog: CCR2331322188. | |
| DACN(Tos,Mal) | SPAAC & SPANC Click Reaction. Group: Dbco. CAS No. 2411082-28-3. Molecular formula: C22H25N3O5S. Mole weight: 443.5. IUPACName: 1-[4-[5-(4-Methylphenyl)sulfonyl-1,5-diazacyclonon-7-yn-1-yl]-4-oxobutyl]pyrrole-2,5-dione. Canonical SMILES: CC1=CC=C (C=C1)S (=O) (=O)N2CCCN (CC#CC2)C (=O)CCCN3C (=O)C=CC3=O. Catalog: CCR2411082283. | |
| DACN(Tos,Ns) | SPAAC & SPANC Click Reaction. Group: Dbco. Alternative Names: N-(o-Nitrobenzenesulfonyl)-N'-(p-toluenesulfonyl)-4,8-diazacyclononyne. CAS No. 1797508-58-7. Molecular formula: C20H21N3O6S2. Mole weight: 463.5. IUPACName: 1-(4-Methylphenyl)sulfonyl-5-(2-nitrophenyl)sulfonyl-1,5-diazacyclonon-7-yne. Canonical SMILES: CC1=CC=C (C=C1)S (=O) (=O)N2CCCN (CC#CC2)S (=O) (=O)C3=CC=CC=C3[N+] (=O)[O-]. Catalog: CCR1797508587. | |
| DACN(Tos,Suc-NHS) | SPAAC & SPANC Click Reaction. Group: Dbcoterminal alkynes. CAS No. 2411082-26-1. Molecular formula: C22H25N3O7S. Mole weight: 475.5. IUPACName: (2,5-Dioxopyrrolidin-1-yl) 4-[5-(4-methylphenyl)sulfonyl-1,5-diazacyclonon-7-yn-1-yl]-4-oxobutanoate. Canonical SMILES: CC1=CC=C (C=C1)S (=O) (=O)N2CCCN (CC#CC2)C (=O)CCC (=O)ON3C (=O)CCC3=O. Catalog: CCR2411082261. | |
| DACN(Tos,Suc-OH) | CuAAC & Thiol-Yne & Spontaneous Amino-Yne Click Reaction. Group: Terminal alkynes. Alternative Names: 4-Oxo-4-(5-tosyl-2,3,4,5,6,9-hexahydro-7,8-didehydro-1H-1,5-diazonine-1-yl)butanoic acid. CAS No. 2109751-68-8. Molecular formula: C18H22N2O5S. Mole weight: 378.4. IUPACName: 4-[5-(4-Methylphenyl)sulfonyl-1,5-diazacyclonon-7-yn-1-yl]-4-oxobutanoic acid. Canonical SMILES: CC1=CC=C (C=C1)S (=O) (=O)N2CCCN (CC#CC2)C (=O)CCC (=O)O. Catalog: CCR2109751688. | |
| Dacomitinib | Dacomitinib, aslo known as PF-299 and PF-00299804; or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Dacomitinib specifically and irreversibly binds to and inhibits human EGFR subtypes, resulting in inhibition of proliferation and induction of apoptosis in EGFR-expressing tumor cells. EGFRs play major roles in tumor cell proliferation and tumor vascularization, and are often overexpressed or mutated in various tumor cell types. Synonyms: dacomitinib; PF-00299804; PF00299804; PF 00299804; PF299804; PF-299804; PF 299804; PF-299; PF 299; PF299. CAS No. 1110813-31-4. Molecular formula: C24H25ClFN5O2. Mole weight: 469.945. | |
| Dacomitinib | Dacomitinib (PF-00299804) is a specific and irreversible inhibitor of the ERBB family of kinases with IC 50 s of 6 nM, 45.7 nM and 73.7 nM for EGFR , ERBB2 , and ERBB4 , respectively [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-00299804; PF-299804. CAS No. 1110813-31-4. Pack Sizes: 10 mM * 1 mL; 5 mg; 10 mg; 50 mg; 100 mg; 200 mg. Product ID: HY-13272. | |
| Dacomitinib hydrate | Dacomitinib (PF-00299804) hydrate is an orally active, irreversible pan- ErbB inhibitor. Dacomitinib hydrate can be used in the research of cancers such as metastatic non-small cell lung cancer (NSCLC) [1]. Uses: Scientific research. Group: Signaling pathways. Alternative Names: PF-00299804 hydrate; PF-299804 hydrate. CAS No. 1042385-75-0. Pack Sizes: 5 mg; 10 mg; 50 mg; 100 mg. Product ID: HY-118263. | |
| Dacomitinib Hydrate | Dacomitinib is a second-generation small molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) tyrosine kinase family (ErbB family) with potential anti-tumor activity. Uses: Tyrosine kinase inhibitors. Synonyms: PF-00299804; PF00299804; PF 00299804; PF299804. CAS No. 1042385-75-0. Molecular formula: C24H25ClFN5O2.H2O. Mole weight: 487.96. | |
| Dacomitinib Impurity 1 | Dacomitinib Impurity 1. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C8H3FN4O5. Mole Weight: 254.13. Catalog: APB12399. | |
| Dacomitinib Impurity 10 | Dacomitinib Impurity 10. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3,4-difluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H25F2N5O2. Mole Weight: 453.48. Catalog: APB05285. | |
| Dacomitinib Impurity 10 | Dacomitinib Impurity 10. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2106-05-0. Molecular Formula: C6H5ClFN. Mole Weight: 145.56. Catalog: APB2106050. | |
| Dacomitinib Impurity 11 | Dacomitinib Impurity 11. Uses: For analytical and research use. Group: Impurity standards. CAS No. 13991-36-1. Molecular Formula: C4H5BrO2. Mole Weight: 164.99. Catalog: APB13991361. | |
| Dacomitinib Impurity 11 | Dacomitinib Impurity 11. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((4-chloro-3-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H25ClFN5O2. Mole Weight: 469.94. Catalog: APB05284. | |
| Dacomitinib Impurity 12 | Dacomitinib Impurity 12. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3-chloro-2-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H25ClFN5O2. Mole Weight: 469.94. Catalog: APB05283. | |
| Dacomitinib Impurity 13 | Dacomitinib Impurity 13. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-fluoroquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C23H22ClF2N5O. Mole Weight: 457.9. Catalog: APB05281. | |
| Dacomitinib Impurity 14 | Dacomitinib Impurity 14. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C26H32ClFN6O2. Mole Weight: 515.03. Catalog: APB12400. | |
| Dacomitinib Impurity 15 | Dacomitinib Impurity 15. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(5-cyano-4-((E)-((dimethylamino)methylene)amino)-2-methoxyphenyl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C20H27N5O2. Mole Weight: 369.46. Catalog: APB05282. | |
| Dacomitinib Impurity 16 | Dacomitinib Impurity 16. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H26FN5O2. Mole Weight: 435.49. Catalog: APB05280. | |
| Dacomitinib Impurity 17 | Dacomitinib Impurity 17. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3-chlorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H26ClN5O2. Mole Weight: 451.95. Catalog: APB05279. | |
| Dacomitinib Impurity 2 | Dacomitinib Impurity 2. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 2-chloro-1-fluoro-4-nitrobenzene. CAS No. 350-30-1. Molecular Formula: C6H3ClFNO2. Mole Weight: 175.54. Catalog: APB350301. | |
| Dacomitinib Impurity 2 | Dacomitinib Impurity 2. Uses: For analytical and research use. Group: Impurity standards. Molecular Formula: C8H4N4O6. Mole Weight: 252.14. Catalog: APB12398. | |
| Dacomitinib Impurity 2F3L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3 | Dacomitinib Impurity 3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2250242-14-7. Molecular Formula: C8H4N4O6. Mole Weight: 252.14. Catalog: APB2250242147. | |
| Dacomitinib Impurity 3F4L | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity 3F4LAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.73. | |
| Dacomitinib Impurity 3F4LXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| Dacomitinib Impurity 4 | Dacomitinib Impurity 4. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-(piperidin-1-yl)pyrrolidin-2-one. Molecular Formula: C24H25ClFN5O2. Mole Weight: 469.94. Catalog: APB05290. | |
| Dacomitinib Impurity 5 | Dacomitinib Impurity 5. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 1-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-5-hydroxypyrrolidin-2-one. CAS No. 2190490-31-2. Molecular Formula: C19H16ClFN4O3. Mole Weight: 402.81. Catalog: APB2190490312. | |
| Dacomitinib Impurity 5 | Dacomitinib Impurity 5. Uses: For analytical and research use. Group: Impurity standards. CAS No. 53449-14-2. Molecular Formula: C8H4ClN3O3. Mole Weight: 225.59. Catalog: APB53449142. | |
| Dacomitinib Impurity 6 | Dacomitinib Impurity 6. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: 5-((3-chloro-4-fluorophenyl)amino)-1-(4-((3-chlorophenyl)amino)-7-methoxyquinazolin-6-yl)pyrrolidin-2-one. Molecular Formula: C25H20Cl2FN5O2. Mole Weight: 512.36. Catalog: APB05288. | |
| Dacomitinib Impurity 7 | Dacomitinib Impurity 7. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(3-(3-chloro-4-fluorophenyl)-4-imino-7-methoxy-3,4-dihydroquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H25ClFN5O2. Mole Weight: 469.94. Catalog: APB05289. | |
| Dacomitinib Impurity 7 | Dacomitinib Impurity 7. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2168856-93-5. Molecular Formula: C7H5FN2O4. Mole Weight: 200.13. Catalog: APB2168856935. | |
| Dacomitinib Impurity 8 | Dacomitinib Impurity 8. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-(N-(3-chloro-4-fluorophenyl)acetamido)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C26H27ClFN5O3. Mole Weight: 511.98. Catalog: APB05286. | |
| Dacomitinib Impurity 9 | Dacomitinib Impurity 9. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)but-2-enamide. Molecular Formula: C19H16ClFN4O2. Mole Weight: 386.81. Catalog: APB05287. | |
| Dacomitinib Impurity BDS | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C19H16ClFN4O2. Mole weight: 386.81. | |
| Dacomitinib Impurity C | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 869199-69-9. Molecular formula: C25H27ClFN5O2. Mole weight: 483.97. | |
| Dacomitinib Impurity D | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 869199-67-7. Molecular formula: C26H29ClFN5O2. Mole weight: 497.99. | |
| Dacomitinib Impurity DF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H26FN5O2. Mole weight: 435.50. | |
| Dacomitinib Impurity DFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: N4-(4-Fluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity); N4-(4-FLUOROPHENYL)-7-METHOXYQUINAZOLINE-4,6-DIAMINE; Dacomitinib Impurity DFAJ; CS-0255390; F83326. Grades: ≥95%. CAS No. 1562180-31-7. Molecular formula: C15H13FN4O. Mole weight: 284.29. | |
| Dacomitinib Impurity DFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 2185841-22-7. Molecular formula: C15H11FN4O3. Mole weight: 314.27. | |
| Dacomitinib Impurity E | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H27ClFN5O3. Mole weight: 487.96. | |
| Dacomitinib Impurity SF | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25F2N5O2. Mole weight: 453.49. | |
| Dacomitinib Impurity SFAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Synonyms: Dacomitinib Impurity SFAJ; CS-0255393; F83329; N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine; N4-(3,4-DIFLUOROPHENYL)-7-METHOXY-QUINAZOLINE-4,6-DIAMINE; N4-(3,4-Difluorophenyl)-7-methoxyquinazoline-4,6-diamine (Dacomitinib Impurity). Grades: ≥95%. CAS No. 2117703-26-9. Molecular formula: C15H12F2N4O. Mole weight: 302.28. | |
| Dacomitinib Impurity SFXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. CAS No. 2119689-75-5. Molecular formula: C15H10F2N4O3. Mole weight: 332.26. | |
| Dacomitinib Impurity SL | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25Cl2N5O2. Mole weight: 486.40. | |
| Dacomitinib Impurity SLAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H12Cl2N4O. Mole weight: 335.19. | |
| Dacomitinib Impurity SLXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H10Cl2N4O3. Mole weight: 365.17. | |
| Dacomitinib Impurity WZYG | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C24H25ClFN5O2. Mole weight: 469.95. | |
| Dacomitinib Impurity WZYGAJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H12ClFN4O. Mole weight: 318.74. | |
| Dacomitinib Impurity WZYGXJ | One of the impurities of Dacomitinib. Dacomitinib, aslo known as PF-299 and PF-00299804 or PF299804, is an orally bioavailable, highly selective, second-generation small-molecule inhibitor of the pan-epidermal growth factor receptor (EGFR) family of tyrosine kinases (ErbB family) with potential antineoplastic activity. Grades: ≥95%. Molecular formula: C15H10ClFN4O3. Mole weight: 348.72. | |
| Dacomitinib Z-isomer | Dacomitinib Z-isomer. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (Z)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide. Molecular Formula: C24H25ClFN5O2. Mole Weight: 469.94. Catalog: APB01903. | |
| Dacotinib impurity 1 | Dacotinib impurity 1. Uses: For analytical and research use. Group: Impurity standards. CAS No. 2641759-50-2. Molecular Formula: C24H27ClFN5O5S. Mole Weight: 552.02. Catalog: APB2641759502. | |
| Dacotinib impurity 3 | Dacotinib impurity 3. Uses: For analytical and research use. Group: Impurity standards. CAS No. 574738-64-0. Molecular Formula: C8H5N3O4. Mole Weight: 207.15. Catalog: APB574738640. | |
| Dacotinib Monohydrate | Dacotinib Monohydrate. Uses: For analytical and research use. Group: Impurity standards. Alternative Names: (E)-N-(4-((3-chloro-4-fluorophenyl)amino)-7-methoxyquinazolin-6-yl)-4-(piperidin-1-yl)but-2-enamide hydrate. CAS No. 1042385-75-0. Molecular Formula: C24H25ClFN5O2·H2O. Mole Weight: : 487.95. Catalog: APB1042385750. | |
| Dacthal monoacid | Dacthal monoacid. Group: Biochemicals. Alternative Names: 2,3,5,6-Tetrachloro-1,4-benzenedicarboxylic acid 4-methyl ester. Grades: Highly Purified. CAS No. 887-54-7. Pack Sizes: 5mg, 10mg, 25mg, 50mg, 100mg. Molecular Formula: C9H4Cl4O4. US Biological Life Sciences. |  Worldwide |
| Dactimicin | Dactimicin is an aminoglycoside antibiotic produced by Dactilosporangium matsuzakiense SF-2O52. It has anti-gram-positive and negative bacteria activity. Synonyms: SF-2052. Grades: >98%. CAS No. 73196-97-1. Molecular formula: C18H36N6O6. Mole weight: 432.51. | |
| Dactimicin sulfate | Dactimicin sulfate is an aminoglycoside antibiotic produced by Dactilosporangium matsuzakiense SF-2O52. It has anti-gram-positive and negative bacteria activity. Synonyms: Antibiotic SF 2052 sulfate; L-chiro-Inositol, 4-amino-1,4-dideoxy-3-O-(2,6-diamino-2,3,4,6,7-pentadeoxy-beta-L-lyxo-heptopyranosyl)-6-O-methyl-1-(2-(formimidoylamino)-N-methylacetamido)-, sulfate (1:2), hydrate. Grades: >98%. CAS No. 73245-91-7. Molecular formula: C18H40N6O14S2. Mole weight: 628.67. | |
Our database is helping our users find suppliers everyday.
